Deepverge PLC
LSE:DVRG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (10.7), the stock would be worth GBX-0.23 (251% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.1 | GBX0.15 |
0%
|
| Industry Average | 10.7 | GBX-0.23 |
-251%
|
| Country Average | 10.6 | GBX-0.22 |
-248%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IE |
|
Deepverge PLC
LSE:DVRG
|
1.1m GBP | -7.1 | -0.5 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 225.9 | 4 278.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
197.4B USD | 20 | 29 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.5B USD | 18.7 | 36.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 30.1 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.1B CHF | 16.9 | -124.9 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
294B CNY | 16 | 15.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.5B USD | 19.5 | 26.6 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.9B USD | 32.6 | 50.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 12.2 | 22 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 22.8 | 30.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 6 |
| Median | 10.6 |
| 70th Percentile | 12.9 |
| Max | 338.7 |
Other Multiples
Deepverge PLC
Glance View
DeepVerge Plc is a personal health company, which engages in the development and commercialization of technology and products for the human integumentary system. The company is headquartered in Malahide, Dublin. The company went IPO on 2017-04-05. The firm provides core skin and human testing technology. Its is engaged in collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science. Its collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple partner technologies.
